We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New Point-of-Care Analyzer for Diabetes Management

By HospiMedica staff writers
Posted on 17 Mar 2008
A point-of-care (POC) diabetes analyzer monitors a patient's glycemic control and helps physicians to encourage patient compliance by delivering actionable test results during a patient visit.

The DCA Vantage immunoassay analyzer is intended for diabetes management, and it provides precise and accurate quantitative test results for glycosylated hemoglobin, (HbA1c) levels in whole blood. More...
With a single urine sample, the analyzer also provides quantitative test results for low levels of Albumin, Creatinine, and A/C Ratio in the physician office or clinic. Physicians can enter a patient identification (ID) via touch screen or barcode and view the on-board printed reports and HbA1c patient trending graphs. An on-board memory can store up to 4000 results with practical sorting capabilities. Physicians can also download the patient results to an external hospital information system.

Simple, convenient testing is enabled by an intuitive color touch-screen display. The operator loads the test cartridge which includes the patient sample onto the system; the system then automatically performs the test procedure, stores the patient results and displays, prints and uploads the results to the laboratory information systems (LIS) or to hospital information systems (HIS) for sites that require compliance and control of decentralized testing. In addition, features such as operator ID entry, quality control reminders, test lockout, remote access, and adjustable correlation to reference methods are also available. Other features include the ability to adjust correlation parameters so that reference assays can be matched to standardized results over multiple systems. The DCA Vantage Analyzer is a product of Siemens Healthcare (Munich, Germany).

"The DCA Vantage Analyzer builds on the proven technology and performance of its predecessor, the DCA 2000+ while adding new capabilities our customers need in their daily practice,” said Arnd Kaldowski, senior vice president of POC business at Siemens Healthcare Diagnostics. "Siemens strives to continuously deliver systems that provide tests with proven clinical benefit and that fulfill the needs of our customers concerning ease of use and data management in the point-of-care setting.”


Related Links:
Siemens Healthcare

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
X-Ray Meter
Cobia SENSE
Exam Table
PF400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.